AMT
26
2
IP
37
3
VTR
67
-2
EXC
51
-3
PAYX
39
-2
DVA
47
-4
ORLY
43
2
EQR
47
2
OKE
67
2
DG
68
-6
RL
66
-3
NWSA
82
3
CCL
89
-3
EXR
24
-2
CL
64
2
PCG
74
-3
SO
50
4
CPB
35
-4
DE
43
-2
SIG
50
3
AMT
26
2
IP
37
3
VTR
67
-2
EXC
51
-3
PAYX
39
-2
DVA
47
-4
ORLY
43
2
EQR
47
2
OKE
67
2
DG
68
-6
RL
66
-3
NWSA
82
3
CCL
89
-3
EXR
24
-2
CL
64
2
PCG
74
-3
SO
50
4
CPB
35
-4
DE
43
-2
SIG
50
3
Financhill
Back

bioAffinity Technologies, Inc. 10K Form

Sell
20

BIAF
bioAffinity Technologies, Inc.

Last Price:
$1.23
Seasonality Move:
-21.35%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BIAF News And Ratings

See the #1 stock for the next 7 days that we like better than BIAF

BIAF Financial Statistics

Sales & Book Value

Annual Sales: $9.4M
Cash Flow: $-2.5M
Price / Cash Flow: 0
Annual Sales: $2.57
Price / Book: 0.63

Profitability

EPS (TTM): -16.12580
Net Income (TTM): $-14.7M
Gross Margin: $2.8M
Return on Equity: -529.1%
Return on Assets: -211.1%

bioAffinity Technologies, Inc. Earnings Forecast

Key bioAffinity Technologies, Inc. Financial Ratios

  • The Gross Profit Margin over the past 6 years for BIAF is 29.62%.
  • The Selling, General & Administrative Expenses for BIAF have been equal to 106.21% of Gross Profit Margin.
  • The Research & Development expenses have been 19.04% of Revenue.
  • The Net Earning history of BIAF is -96.56% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 2 years.

bioAffinity Technologies, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: BIAF
Website: bioaffinitytech.com

Debt

Debt-to-Equity Ratio: 0.08
Current Ratio: 3.65
Quick Ratio: 3.43

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

BIAF Technical Analysis vs Fundamental Analysis

Sell
20
bioAffinity Technologies, Inc. (BIAF) is a Sell

Is bioAffinity Technologies, Inc. a Buy or a Sell?